Price range: $42.00 through $110.00
All products are provided either as a liquid suspension in a 30mL vial or as raw powder packaged in an individual bag.
1mg/mL solution (30mg/30mL)
 |
|
 |
|
| Clinical data | |
|---|---|
| Other names | MK-906; YM-152; L-652,931; 17β-(N-tert-Butylcarbamoyl)-4-aza-5α-androst-1-en-3-one; N-(1,1-Dimethylethyl)-3-oxo-4-aza-5α-androst-1-ene-17β-carboxamide |
| AHFS/Drugs.com | Monograph |
| MedlinePlus | a698016 |
| License data |
|
| Pregnancy category |
|
| Routes of administration |
By mouth |
| Drug class | 5α-Reductase inhibitor |
| ATC code | |
| Pharmacokinetic data | |
| Bioavailability | 65%[5] |
| Protein binding | 90%[5] |
| Metabolism | Liver (CYP3A4, ALDH)[5] |
| Elimination half-life | Adults: 5–6 hours[5] Elderly: >8 hours[5] |
| Excretion | Feces: 57%[5] Urine: 40%[5] |
| Identifiers | |
| CAS Number | |
| PubChem CID | |
| IUPHAR/BPS | |
| DrugBank | |
| ChemSpider | |
| UNII | |
| KEGG | |
| ChEBI | |
| ChEMBL | |
| CompTox Dashboard (EPA) | |
| ECHA InfoCard | 100.149.445 |
| Chemical and physical data | |
| Formula | C23H36N2O2 |
| Molar mass | 372.553 g·mol−1 |
| 3D model (JSmol) | |
| (verify) | |
**The information provided is intended solely for educational purposes and should not be considered a replacement for professional medical advice. Additionally, it is important to note that research chemicals are intended solely for laboratory study by professional researchers and are not intended for human consumption.**
